Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Prevention of Postpartum-Related Breast Cancer
NCT05557877Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Mar 2023
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in breast cancer, sponsored by Mayo Clinic. Started Mar 2023; status: recruiting.
02
Drugs
aspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05557877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05557877.